Sonic Healthcare Ltd (SKHCF) 15.4900 $SKHCF
Diadexus, Inc. and Sonic Healthcare USA Sign National Agreement for PLAC(R) Activity Test
Marketwire Canada - Mon May 23, 8:00AM CDT
Partnering With Fifth Largest U.S. Laboratory Service Provider to Launch Broadly the PLAC(R) Activity Test, an FDA-Cleared Test for Coronary Heart Disease Risk Assessment
North America Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019
M2 - Tue Jan 26, 4:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/5jg3ps/clinical) has announced the addition of the "Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019 - North America Version " report to their offering. A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations. Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage. "Clinical Laboratory, Molecular Diagnostic and Genomic Testing Services - 2016 to 2019 North America Version" Features - Data that analysts and planners can use - Hundreds of pages of information including a complete list of Current 2015 United States Medicare Fee Payment Schedules to help sharpen your pricing - Make facilities planning decisions - Forecast demand for new testing regimes or technologies - Make research investment decisions Key Topics Covered: 1. Introduction and Market Definition 2. Market Overview 3. Market Trends 4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments 5. Country Market Sizes - North America 6. The Future of the Clinical Laboratory Companies Mentioned - Acibadem Labmed Laboratory - ACM Medical Laboratory - Adicon Clinical Laboratories, Inc. - Alere Inc - American Pathology Partners, Inc. - ARUP Laboratories, Inc. - Ascend Clinical, LLC - Aurora Diagnostics, LLC - Biomnis (France) - Bio-Reference Laboratories, Inc. - Bioscientia Institut fuer Medizinische Diagnostik GmbH - BP Lab - Caris Life Sciences, Inc. - Centrex Clinical Laboratories, Inc. - Clarient, Inc. - Clongen Laboratories LLC - CompuNet Clinical Laboratories, LLC - Diagn?sticos da Am?rica (DASA) - DL Reference Laboratory - Enzo Biochem, Inc. - Exagen Diagnostics, Inc. - Genomic Health, Inc. - Genzyme Corporation - Gribbles Pathology - Integrated Regional Laboratories, Inc. - Predictive Biosciences, Inc. - Psychemedics Corp. - Rosetta Genomics Inc. - Signal Genetics LLC - Solstas Lab Partners - Sonic Healthcare Limited - Spectra Spectra Laboratories, Inc. - The Doctor's Laboratory (Sonic Healthcare U.K.) - Unilabs SA - Vira Cor-Ibt Laboratories For more information visit http://www.researchandmarkets.com/research/5jg3ps/clinical
PMD: 13.34 (-0.18), BRLI: 34.69 (+0.08), ALR: 41.99 (-0.31), ARDX: 8.46 (+0.33), GHDX: 26.40 (+1.10), ENZ: 5.67 (+0.22)
Asia Pacific Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019
M2 - Mon Jan 25, 7:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/sx57w8/clinical) has announced the addition of the "Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019 - Asia Pacific Version" report to their offering. A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations. Exciting technical developments especially in the area of molecular diagnostics and pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage. Key Topics Covered: 1. Introduction and Market Definition 2. Market Overview 2.1 Market Participants 2.2 Market Segments 2.3 Industry Structure 2.4 Profiles of Key Companies 2.5 National and Regional Diversity 3. Market Trends 3.1 Factors Driving Growth 3.2 Factors Limiting Growth 3.3 Automation 3.4 Environment and Evolution 3.5 Diagnostic Technology Development 4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments 5. Country Markets - Asia Pacific 6. The Future of the Clinical Laboratory Companies Mentioned - Acibadem Labmed Laboratory - ACM Medical Laboratory - Adicon Clinical Laboratories, Inc. - Alere Inc - American Pathology Partners, Inc. - ARUP Laboratories, Inc. - Ascend Clinical, LLC - Aurora Diagnostics, LLC - Biomnis (France) - Bio-Reference Laboratories, Inc. - Claymon Biomnis Laboratories Ltd. - Clinical Reference Laboratory, Inc. - Clongen Laboratories LLC - CompuNet Clinical Laboratories, LLC - Diagn?sticos da Am?rica (DASA) - DL Reference Laboratory - Enzo Biochem, Inc. - Exagen Diagnostics, Inc. - Genomic Health, Inc. - Genzyme Corporation - Laboratory Corporation of America - Lifelabs Medical Laboratory Services - Medicus Phillipines Inc. - MEDTOX Scientific, Inc. - Mid America Clinical Laboratories, LLC - Myriad Genetics, Inc. - Pathology Inc. - Rosetta Genomics Inc. - Signal Genetics LLC - Solstas Lab Partners - Sonic Healthcare Limited - Spectra Spectra Laboratories, Inc. - The Doctor's Laboratory (Sonic Healthcare U.K.) - Unilabs SA - Vira Cor-Ibt Laboratories For more information visit http://www.researchandmarkets.com/research/sx57w8/clinical
MYGN: 30.91 (+0.83), BRLI: 34.69 (+0.08), ALR: 41.99 (-0.31), ARDX: 8.46 (+0.33), GHDX: 26.40 (+1.10), ENZ: 5.67 (+0.22)
Latin America, Africa & Middle East Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2016 to 2019
M2 - Mon Jan 25, 3:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/nlg4t5/clinical) has announced the addition of the "Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019 - Latin America, Africa & Middle East" report to their offering. Exciting technical developments especially in the area of molecular diagnostics and pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage. Report Highlights - Hundreds of pages of information including a complete list of Current 2015 United States Medicare Fee Payment Schedules to help sharpen your pricing - Make facilities planning decisions - Forecast demand for new testing regimes or technologies - Make research investment decisions - Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand - Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges - Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth - Again, assistance in using the information is normally provided without additional charges Key Topics Covered: 1. Introduction and Market Definition 2. Market Overview 2.5 National and Regional Diversity 3. Market Trends 4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments 5. Country Markets - Latin America, Africa & The Middle East 6. The Future of the Clinical Laboratory Key Companies - Quest Diagnostics - Laboratory Corporation of America - Lifelabs Medical Laboratory Services - Genzyme Corporation - Sonic Healthcare Limited - Exagen Diagnostics, Inc. - Clongen Laboratories LLC - Clinical Reference Laboratory, Inc. - Rosetta Genomics Inc. - Mid America Clinical Laboratories, LLC - Alere Inc - Caris Life Sciences, Inc. - Psychemedics Corp. - Aurora Diagnostics, LLC - DL Reference Laboratory - Myriad Genetics, Inc. - Pathology Inc. - Gribbles Pathology - BP Lab - Adicon Clinical Laboratories, Inc. - Diagn?sticos da Am?rica (DASA) - Medicus Phillipines Inc. - Kingmed Diagnostics - Ascend Clinical, LLC - Unilabs SA - American Pathology Partners, Inc. - Centrex Clinical Laboratories, Inc. - Integrated Regional Laboratories, Inc. - Vira Cor-Ibt Laboratories - Clarient, Inc. - Genomic Health, Inc. - ARUP Laboratories, Inc. - MEDTOX Scientific, Inc. - Solstas Lab Partners - Predictive Biosciences, Inc. For more information visit http://www.researchandmarkets.com/research/nlg4t5/clinical
PMD: 13.34 (-0.18), MYGN: 30.91 (+0.83), ALR: 41.99 (-0.31), ARDX: 8.46 (+0.33), GHDX: 26.40 (+1.10), DGX: 77.83 (+2.10)
Europe Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019
M2 - Fri Jan 22, 9:41AM CST
Research and Markets (http://www.researchandmarkets.com/research/qbs9gc/clinical) has announced the addition of the "Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019 - Europe Version" report to their offering. A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations. Exciting technical developments especially in the area of molecular diagnostics and pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage. Make investment decisions and valuations with confidence using the latest data. Key Topics Covered: 1. Introduction and Market Definition 2. Market Overview 3. Market Trends 4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments 6. Country Markets - Europe 7. The Future of the Clinical Laboratory Companies Mentioned - Quest Diagnostics - Laboratory Corporation of America - Lifelabs Medical Laboratory Services - ACM Medical Laboratory - Spectra Spectra Laboratories, Inc. - Bio-Reference Laboratories, Inc. - Signal Genetics LLC - CompuNet Clinical Laboratories, LLC - Genzyme Corporation - Sonic Healthcare Limited - Exagen Diagnostics, Inc. - Clongen Laboratories LLC - Clinical Reference Laboratory, Inc. - Rosetta Genomics Inc. - Psychemedics Corp. - Aurora Diagnostics, LLC - DL Reference Laboratory - Myriad Genetics, Inc. - Bioscientia Institut fuer Medizinische Diagnostik GmbH - Acibadem Labmed Laboratory - Claymon Biomnis Laboratories Ltd. - Biomnis (France) - The Doctor's Laboratory (Sonic Healthcare U.K.) - Unilabs SA - American Pathology Partners, Inc. - Centrex Clinical Laboratories, Inc. - Integrated Regional Laboratories, Inc. - Vira Cor-Ibt Laboratories - Clarient, Inc. - Genomic Health, Inc. - ARUP Laboratories, Inc. - MEDTOX Scientific, Inc. - Solstas Lab Partners - Predictive Biosciences, Inc. - Enzo Biochem, Inc. For more information visit http://www.researchandmarkets.com/research/qbs9gc/clinical
PMD: 13.34 (-0.18), MYGN: 30.91 (+0.83), BRLI: 34.69 (+0.08), ARDX: 8.46 (+0.33), GHDX: 26.40 (+1.10), ENZ: 5.67 (+0.22), DGX: 77.83 (+2.10)
The Road Ahead - Featured Research on Danone, Industria de Diseno Textil, Shin-Etsu Chemical, and Sonic Healthcare
ACCESSWIRE - Fri Jan 22, 7:35AM CST
NEW YORK, NY / ACCESSWIRE / January 22, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Danone SA (OTC: DANOY), Industria de Diseno Textil SA (OTC: IDEXY), Shin-Etsu Chemical Co. Ltd. (OTC: SHECY) and Sonic Healthcare Ltd. (OTC: SKHCY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Analysis of the Western European Clinical Laboratories Market 2012-2020, with 2015 as Base Year
M2 - Tue Jan 05, 9:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/tqkt5v/analysis_of_the) has announced the addition of the "Analysis of the Western European Clinical Laboratories Market" report to their offering. Laboratory consolidations and outsourcing of services are providing more opportunities to the clinical labs. How the market is going to shape up and how the laboratory services structure is transforming in Western Europe is analyzed in this research service. The study provides market overview, market engineering measurements and revenue forecasts, company profiling, and key trends for the clinical laboratory market and its segments, namely Independent reference laboratories, hospital laboratories, and physician office laboratories. Regional analysis includes Western European countries, such as the United Kingdom, Germany, France, Italy, Spain, BENELUX, and Scandinavia. The period covered in the study is 2012-2020, with 2015 as base year. Key Topics Covered: 1. Executive Summary 2. Market Overview 3. Competitive Playbook 4. External Challenges - Drivers and Restraints 5. Forecasts and Trends - Total Clinical Laboratories Market 6. Key Company Profiles 7. SWOT Analysis 8. The United Kingdom Analysis 9. Germany Analysis 10. France Analysis 11. Italy Analysis 12. Spain Analysis 13. Benelux Analysis 14. Scandinavia Analysis 15. The Last Word 16. Appendix Companies Mentioned - Biomnis - Groupe LCD - LADR - Labco - Laboratorio Dr Echevarne - Sana Kliniken - Sonic Healthcare - Synlab - Unilabs For more information visit http://www.researchandmarkets.com/research/tq...sis_of_the
United States Clinical Laboratory Services Market Report 2015
M2 - Wed Dec 16, 3:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/5fp5b5/clinical) has announced the addition of the "Clinical Laboratory Services Market" report to their offering. Clinical Laboratory Services Market, provides an in-depth market overview, a total market analysis, analysis by laboratory type, and by routine and specialty testing and a review of the latest trends driving growth. Revenues and forecasts, segment breakouts and market share presented are for the U.S. market, but international clinical lab service markets are estimated and forecasted in this report. Laboratory services are a key component of the healthcare system and an important part of the commercialization of in vitro diagnostic tests. It is estimated that approximately 80% of physician's diagnoses are a result of laboratory tests, and a fair number of these tests are sent to clinical lab service providers. There is constant pressure to reduce healthcare spending, and that in turn is shifting healthcare utilization in favor of the laboratory. This has not escaped the attention of major competitors who operate in the industry, and those planning to enter. Key market data provided includes: - The US Clinical Laboratry Market and Forecast - Markets for Tissue Pathology - Markets for Routine Chemistry Testing - Markets for Non-Tissue Molecular - Market for Toxicology/Drug Abuse Testing - European Market and Forecast - Asian Pacific Market and Forecast - Latin American Market and Forecast - Hospital, Physician and Independent Lab Statistics - Major Tests Performed by Clinical Lab Companies A competitive analysis of leading clinical laboratory providers includes: - Bio-Reference Laboratories - Da Vita Healthcare - Quest Diagnostics, Inc. - Laboratory Corporation of America (LabCorp) - Genomic Health - Genoptix - Sonic Healthcare - Myriad Genetics - Genzyme Corporation - Clarient, Inc. - Spectra Laboratories Key Topics Covered: - Executive Summary - Industry Overview - Issues And Trends In The Clinical Laboratory Industry - Leading Market Participants - Market Trends And Summary - List Of Major Companies For more information visit http://www.researchandmarkets.com/research/5fp5b5/clinical
MYGN: 30.91 (+0.83), BRLI: 34.69 (+0.08), DGX: 77.83 (+2.10), GHDX: 26.40 (+1.10)
ACCC will review Sonic Healthcare's proposed acquisition of Adelaide Pathology Partners
M2 - Mon Nov 09, 1:26AM CST
The Australian Competition and Consumer Commission will conduct a public merger review of the proposed acquisition of Adelaide Pathology Partners (APP) by Sonic Healthcare Limited and its subsidiary, Clinpath Laboratories Pty Ltd, (together, Sonic).
Global Clinical Laboratory Tests Market Analysis 2015 - Forecasts To 2020 for the $148 Billion Industry
M2 - Wed Nov 04, 4:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/kp9dqc/clinical) has announced the addition of the "Clinical Laboratory Tests Market Analysis By Product And Segment - Forecasts To 2020" report to their offering. The global market for clinical laboratory is expected to reach USD 148.82 billion by 2020, growing at an estimated CAGR of 6.8% from 2014 to 2020 Growing prevalence of chronic diseases and the development of novel laboratory testing methodologies is expected to drive the clinical laboratory tests market through to 2020. Due to the fact that results from clinical laboratory tests are the fundamental basis upon which medical practitioners and healthcare providers form their diagnosis and prognosis for the prevention and treatment for a range of diseases, clinical laboratory tests are critical to the global healthcare and medical fraternity. A growing global prevalence of medical conditions such as diabetes, obesity and other metabolic abnormalities coupled with increasing patient awareness levels is expected to boost market growth during the forecast period. For the purpose of this study, the report has segmented the clinical laboratory tests market on the basis of test type, laboratory type - Global Clinical Laboratory Tests, Test Type Outlook (Revenue, USD Billion, 2012 - 2020) - Complete Blood Count Market, by Laboratory Type - HGB/HCT Tests Market, by Laboratory Type - Basic Metabolic Panel Market, by Laboratory Type - BUN Creatinine Tests Market, by Laboratory Type - Electrolytes Testing Market, by Laboratory Type - HbA1c Tests Market, by Laboratory Type - Comprehensive Metabolic Panel Market, by Laboratory Type - Liver Panel Tests Market, by Laboratory Type - Renal Panel Tests Market, by Laboratory Type - Lipid Panel Tests Market, by Laboratory Type - Clinical Laboratory Tests Regional Outlook (Revenue, USD Billion, 2012 - 2020) Competitive Landscape - Siemens - Charles River Laboratories - Quest Diagnostics Inc. - Bioscientia Healthcare - Sonic Healthcare Limited - Abbott Laboratories - Bio-Reference Laboratories - Labco S.A. - Healtscope Limited - Spectra Laboratories - Laboratory corporation of America Holdings (Labcorp) - ARUP Laboratories - Genoptix Medical Laboratory - Qiagen - Clarient Inc. - Genzyme Corporation For more information visit http://www.researchandmarkets.com/research/kp9dqc/clinical
ABT: 37.77 (+0.38), BRLI: 34.69 (+0.08), DGX: 77.83 (+2.10), LH: 127.46 (+1.76)
Ariosa Diagnostics' Harmony(TM) Prenatal Test now performed in Australia and United Kingdom at Sonic Healthcare laboratories
PR Newswire Europe - Tue Oct 13, 9:00AM CDT
Non-invasive prenatal test assessing Down syndrome risk expands international reach
ROG: 63.38 (+1.37)
Healthcare Cloud Leader hc1.com(R) Announces Record Growth and Client Expansion
Marketwired - Thu Sep 17, 7:30AM CDT
hc1.com, inventor of the world's leading healthcare relationship management platform, today announced that it has achieved record sales growth fueled by new client additions and its best in class annually recurring revenue (ARR) renewal rate of 129%.
Drug of Abuse Testing Market Development and Demand Forecast to 2020 - The Market is Expected to Reach $3.9 billion in 2020
M2 - Wed Aug 19, 6:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9lvnjl/global_industry) has announced the addition of the "Global Industry Insight: Drug of Abuse Testing Market Development and Demand Forecast to 2020" report to their offering. Drug of abuse testing is based on diagnosing drug addiction, also called substance use disorder, requiring a thorough evaluation and often includes an assessment by a psychiatrist, a psychologist, or a licensed alcohol and drug counselor. Blood, urine or other lab tests are used to assess drug use, but they're not a diagnostic test for addiction. These tests may be used for monitoring treatment. The testing technologies consist of immunoassay technique and chromatography technique, used for both onsite as well as laboratory testing. Key findings of Drug of Abuse Testing Market: - Onsite testing market is more than double the size of laboratory testing market due to ease of use, cost effectiveness and immediate results. - North America was the largest market by geography for drug abuse testing in 2014, with 76.4% share of the total market. It was followed by Europe with 16.4% share and Asia with a 4.7% share of the total market. Report Coverage - Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis - Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market - Uncovers potential demands in the market Key Topics Covered: 1. Research Scope & Methodology 2. Executive Summary 3. Market Outlook 4. Global Market Size & Forecast (2011-2020) 5. Global Market Breakdown by Type of Test 6. Global Market Breakdown by Sample 7. Global Market Breakdown by Region 8. Competitive Analysis 9. Company Profiles 10. Appendix Companies Mentioned - Abbott Laboratories - Alere Inc. - Bio-Rad Laboratories, Inc. - Laboratory Corporation of America Holdings - Psychemedics Corporation - Quest Diagnostics - Randox Laboratories Ltd - Roche Holding Limited - Sonic Healthcare - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/9l...l_industry
PMD: 13.34 (-0.18), ABT: 37.77 (+0.38), DGX: 77.83 (+2.10), LH: 127.46 (+1.76), ALR: 41.99 (-0.31)
Belgian Start-up UgenTec Receives Funding from European Investors
PR Newswire Europe - Fri Apr 10, 8:00AM CDT
-- Develops FastFinder Software Platform for Automating DNA Analysis
Global Alcohol Breathalyzer And Drug Testing Equipment Report 2014-2020 - Market Shares, Strategies, and Forecasts
M2 - Wed Nov 26, 5:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/rf99gs/alcohol) has announced the addition of Wintergreen Research, Inc's new report "Global Alcohol Breathalyzer And Drug Testing Equipment Report 2014-2020 - Market Shares, Strategies, and Forecasts" to their offering. The drug testing segment starts out as a low 29% percent of the drug and alcohol abuse detection market in 2013 and grows to be 66% of the market by 2020 responding in part to the sheer danger of the heroin drugs. The terrorists have promised to be flooding the US with opiates and heroin, wrecking the country from the inside. This is a tremendous danger, cheap heroin. The drug testing represents a deterrent as significant as military deterrent or more so to protect the citizens from direct attack. Alternatives to bars are emerging. Sports clubs have sprung up all over, creating clubs where people can meet and interact without going to a bar. The fact that alternative socialization venues exist is making it easier to enforce laws against drinking and driving. Alcohol related accidents kill someone every 31 minutes and injure someone every 2 minutes in the US. Alcohol and drugs cause serious disruption to the workforce when present among employees. Breath and saliva contain markers that can be used to monitor alcohol abuse, drug abuse, and the health status of patients. In the U.S. nearly half of road accidents are estimated to occur due to excessive alcohol consumption and drug abuse. Similarly, the number of deaths soared by 26% in Britain due to drunk driving in 2012. Thus, alcohol enforcements remain a priority for governments across the globe. Governments of various countries are strictly enforcing safety laws and are heavily emphasizing on work safety issues. Moreover, they are compelling organizations, vehicle owners and others to install portable breath analyzers at their work places. In the global breath analysis market, the fuel cell technology segment accounted for the largest share and is anticipated to lead the market during the forecast period. The growth in this segment is attributed to technology efficiency, accuracy and the increasing popularity of breath testing devices. Key Topics: - AMP Amphetamine Testing - Alcohol Breathalyzer - BZO Benzodiazepines Testing - Breath Analyzer - Breath Test Evidence - COC Cocaine Testing - Cannabis Testing - Combination Module Testing - Drug Abuse Test Kits - Drug Identification Kits - Drug Test Key Cup - Drug Testing - Employee Alcohol and Drug Testing - Fuel Cell Sensor - Hair Drug Test Kits - Healthcare Biosensor - Healthcare Breath Diagnostic Test - K2 - Law Enforcement Testing - OPI Morphrine Testing - Oral Fluid Drug Test Kit - Personal Breathalyzer - Rapid Detect Dip Drug - Saliva Drug Test Kits - Spice - Synthetic Drug Compounds - THC Testing - Urine Drug Test Kits Market Participants: - AK Solutions - Abbott Laboratories - Alcolizer - Alcovisor - Applied Nanodetectors - Bio-Rad Laboratories - Breathalyzers - CLIAWaived - DOT Breathalyzers - EBI - Express Diagnostic - KHN Solutions LLC Bactrack Breathalyzers - Lab Corp - Ladybug Teknologies - National Patent Analytic Systems (NPAS) / Datamaster - OmegaPoint Systems - Psychemedic - Quest Products - Randox Laboratories - Rapid Detect Inc. - Rapid Exams - Roche Diagnostics - Sonic Healthcare - Test Country - Thermo Fisher Scientific - TruTouch - okyoflash - uVera Diagnostics For more information visit http://www.researchandmarkets.com/research/rf99gs/alcohol
ABT: 37.77 (+0.38)
Global Drug Abuse Testing Market Outlook 2018 - Increase in Number of Collaborations and M&A
M2 - Thu Nov 06, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/dtmmdp/global_drug_abuse) has announced the addition of the "Global Drug Abuse Testing Market 2014-2018" report to their offering. The Global Drug Abuse Testing market to grow at a CAGR of 4.71% over the period 2013-2018 To calculate the market size, the report considers the revenue generated from sales of drug abuse testing solutions, which includes drug abuse testing kits and systems. The technologies primarily considered in the report are immunoassay and chromatography. One of the major trends upcoming in the market is the increase in the number of collaborations and M&A in the market. This strategy helps vendors to expand their portfolio as well as improve the quality and performance of their products. According to the report, the rising consumption of illicit drugs is a major driver in the Global Drug Abuse Testing market as the use of illicit drugs in developed as well as in developing countries is increasing worldwide. Further, the report states that one of the key challenges that the market faces is the inability of drug abuse testing products to detect low-dose designer drugs. The detection of designer drugs such as ecstasy, Rohypnol, and LSD is very difficult. Key Vendors - Bio-Rad Laboratories - Danaher - F. Hoffmann-La Roche - Siemens - Thermo Fisher Scientific Other Prominent Vendors - Abbott Laboratories - Agilent Technologies - Alere - Biomedical Diagnostics - Branan Medical - OraSure Technologies - PerkinElmer - Psychemedics - Quest Diagnostic - Randox Laboratories - Sigma-Aldrich - Sonic Healthcare - Waters Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Overview - Market Landscape - Market Segmentation by Technique - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/dt...drug_abuse
PMD: 13.34 (-0.18), ABT: 37.77 (+0.38), A: 46.12 (+0.76), DHR: 98.79 (+1.03), PKI: 53.18 (+0.83), OSUR: 6.87 (-0.07)
DynaLIFE(DX) Seeks Information on AHS Decision to Award Australian Company Lab Services
CNW Group - Tue Oct 21, 4:17PM CDT
Clarification important for Alberta Patients
Diadexus, Inc. and Sonic Healthcare USA Sign National Agreement for PLAC(R) Activity Test
Marketwire Canada - Mon May 23, 8:00AM CDT
Partnering With Fifth Largest U.S. Laboratory Service Provider to Launch Broadly the PLAC(R) Activity Test, an FDA-Cleared Test for Coronary Heart Disease Risk Assessment
North America Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019
M2 - Tue Jan 26, 4:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/5jg3ps/clinical) has announced the addition of the "Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019 - North America Version " report to their offering. A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations. Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage. "Clinical Laboratory, Molecular Diagnostic and Genomic Testing Services - 2016 to 2019 North America Version" Features - Data that analysts and planners can use - Hundreds of pages of information including a complete list of Current 2015 United States Medicare Fee Payment Schedules to help sharpen your pricing - Make facilities planning decisions - Forecast demand for new testing regimes or technologies - Make research investment decisions Key Topics Covered: 1. Introduction and Market Definition 2. Market Overview 3. Market Trends 4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments 5. Country Market Sizes - North America 6. The Future of the Clinical Laboratory Companies Mentioned - Acibadem Labmed Laboratory - ACM Medical Laboratory - Adicon Clinical Laboratories, Inc. - Alere Inc - American Pathology Partners, Inc. - ARUP Laboratories, Inc. - Ascend Clinical, LLC - Aurora Diagnostics, LLC - Biomnis (France) - Bio-Reference Laboratories, Inc. - Bioscientia Institut fuer Medizinische Diagnostik GmbH - BP Lab - Caris Life Sciences, Inc. - Centrex Clinical Laboratories, Inc. - Clarient, Inc. - Clongen Laboratories LLC - CompuNet Clinical Laboratories, LLC - Diagn?sticos da Am?rica (DASA) - DL Reference Laboratory - Enzo Biochem, Inc. - Exagen Diagnostics, Inc. - Genomic Health, Inc. - Genzyme Corporation - Gribbles Pathology - Integrated Regional Laboratories, Inc. - Predictive Biosciences, Inc. - Psychemedics Corp. - Rosetta Genomics Inc. - Signal Genetics LLC - Solstas Lab Partners - Sonic Healthcare Limited - Spectra Spectra Laboratories, Inc. - The Doctor's Laboratory (Sonic Healthcare U.K.) - Unilabs SA - Vira Cor-Ibt Laboratories For more information visit http://www.researchandmarkets.com/research/5jg3ps/clinical
PMD: 13.34 (-0.18), BRLI: 34.69 (+0.08), ALR: 41.99 (-0.31), ARDX: 8.46 (+0.33), GHDX: 26.40 (+1.10), ENZ: 5.67 (+0.22)
Asia Pacific Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019
M2 - Mon Jan 25, 7:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/sx57w8/clinical) has announced the addition of the "Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019 - Asia Pacific Version" report to their offering. A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations. Exciting technical developments especially in the area of molecular diagnostics and pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage. Key Topics Covered: 1. Introduction and Market Definition 2. Market Overview 2.1 Market Participants 2.2 Market Segments 2.3 Industry Structure 2.4 Profiles of Key Companies 2.5 National and Regional Diversity 3. Market Trends 3.1 Factors Driving Growth 3.2 Factors Limiting Growth 3.3 Automation 3.4 Environment and Evolution 3.5 Diagnostic Technology Development 4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments 5. Country Markets - Asia Pacific 6. The Future of the Clinical Laboratory Companies Mentioned - Acibadem Labmed Laboratory - ACM Medical Laboratory - Adicon Clinical Laboratories, Inc. - Alere Inc - American Pathology Partners, Inc. - ARUP Laboratories, Inc. - Ascend Clinical, LLC - Aurora Diagnostics, LLC - Biomnis (France) - Bio-Reference Laboratories, Inc. - Claymon Biomnis Laboratories Ltd. - Clinical Reference Laboratory, Inc. - Clongen Laboratories LLC - CompuNet Clinical Laboratories, LLC - Diagn?sticos da Am?rica (DASA) - DL Reference Laboratory - Enzo Biochem, Inc. - Exagen Diagnostics, Inc. - Genomic Health, Inc. - Genzyme Corporation - Laboratory Corporation of America - Lifelabs Medical Laboratory Services - Medicus Phillipines Inc. - MEDTOX Scientific, Inc. - Mid America Clinical Laboratories, LLC - Myriad Genetics, Inc. - Pathology Inc. - Rosetta Genomics Inc. - Signal Genetics LLC - Solstas Lab Partners - Sonic Healthcare Limited - Spectra Spectra Laboratories, Inc. - The Doctor's Laboratory (Sonic Healthcare U.K.) - Unilabs SA - Vira Cor-Ibt Laboratories For more information visit http://www.researchandmarkets.com/research/sx57w8/clinical
MYGN: 30.91 (+0.83), BRLI: 34.69 (+0.08), ALR: 41.99 (-0.31), ARDX: 8.46 (+0.33), GHDX: 26.40 (+1.10), ENZ: 5.67 (+0.22)
Latin America, Africa & Middle East Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2016 to 2019
M2 - Mon Jan 25, 3:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/nlg4t5/clinical) has announced the addition of the "Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019 - Latin America, Africa & Middle East" report to their offering. Exciting technical developments especially in the area of molecular diagnostics and pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage. Report Highlights - Hundreds of pages of information including a complete list of Current 2015 United States Medicare Fee Payment Schedules to help sharpen your pricing - Make facilities planning decisions - Forecast demand for new testing regimes or technologies - Make research investment decisions - Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand - Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges - Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth - Again, assistance in using the information is normally provided without additional charges Key Topics Covered: 1. Introduction and Market Definition 2. Market Overview 2.5 National and Regional Diversity 3. Market Trends 4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments 5. Country Markets - Latin America, Africa & The Middle East 6. The Future of the Clinical Laboratory Key Companies - Quest Diagnostics - Laboratory Corporation of America - Lifelabs Medical Laboratory Services - Genzyme Corporation - Sonic Healthcare Limited - Exagen Diagnostics, Inc. - Clongen Laboratories LLC - Clinical Reference Laboratory, Inc. - Rosetta Genomics Inc. - Mid America Clinical Laboratories, LLC - Alere Inc - Caris Life Sciences, Inc. - Psychemedics Corp. - Aurora Diagnostics, LLC - DL Reference Laboratory - Myriad Genetics, Inc. - Pathology Inc. - Gribbles Pathology - BP Lab - Adicon Clinical Laboratories, Inc. - Diagn?sticos da Am?rica (DASA) - Medicus Phillipines Inc. - Kingmed Diagnostics - Ascend Clinical, LLC - Unilabs SA - American Pathology Partners, Inc. - Centrex Clinical Laboratories, Inc. - Integrated Regional Laboratories, Inc. - Vira Cor-Ibt Laboratories - Clarient, Inc. - Genomic Health, Inc. - ARUP Laboratories, Inc. - MEDTOX Scientific, Inc. - Solstas Lab Partners - Predictive Biosciences, Inc. For more information visit http://www.researchandmarkets.com/research/nlg4t5/clinical
PMD: 13.34 (-0.18), MYGN: 30.91 (+0.83), ALR: 41.99 (-0.31), ARDX: 8.46 (+0.33), GHDX: 26.40 (+1.10), DGX: 77.83 (+2.10)
Europe Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019
M2 - Fri Jan 22, 9:41AM CST
Research and Markets (http://www.researchandmarkets.com/research/qbs9gc/clinical) has announced the addition of the "Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019 - Europe Version" report to their offering. A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations. Exciting technical developments especially in the area of molecular diagnostics and pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage. Make investment decisions and valuations with confidence using the latest data. Key Topics Covered: 1. Introduction and Market Definition 2. Market Overview 3. Market Trends 4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments 6. Country Markets - Europe 7. The Future of the Clinical Laboratory Companies Mentioned - Quest Diagnostics - Laboratory Corporation of America - Lifelabs Medical Laboratory Services - ACM Medical Laboratory - Spectra Spectra Laboratories, Inc. - Bio-Reference Laboratories, Inc. - Signal Genetics LLC - CompuNet Clinical Laboratories, LLC - Genzyme Corporation - Sonic Healthcare Limited - Exagen Diagnostics, Inc. - Clongen Laboratories LLC - Clinical Reference Laboratory, Inc. - Rosetta Genomics Inc. - Psychemedics Corp. - Aurora Diagnostics, LLC - DL Reference Laboratory - Myriad Genetics, Inc. - Bioscientia Institut fuer Medizinische Diagnostik GmbH - Acibadem Labmed Laboratory - Claymon Biomnis Laboratories Ltd. - Biomnis (France) - The Doctor's Laboratory (Sonic Healthcare U.K.) - Unilabs SA - American Pathology Partners, Inc. - Centrex Clinical Laboratories, Inc. - Integrated Regional Laboratories, Inc. - Vira Cor-Ibt Laboratories - Clarient, Inc. - Genomic Health, Inc. - ARUP Laboratories, Inc. - MEDTOX Scientific, Inc. - Solstas Lab Partners - Predictive Biosciences, Inc. - Enzo Biochem, Inc. For more information visit http://www.researchandmarkets.com/research/qbs9gc/clinical
PMD: 13.34 (-0.18), MYGN: 30.91 (+0.83), BRLI: 34.69 (+0.08), ARDX: 8.46 (+0.33), GHDX: 26.40 (+1.10), ENZ: 5.67 (+0.22), DGX: 77.83 (+2.10)
The Road Ahead - Featured Research on Danone, Industria de Diseno Textil, Shin-Etsu Chemical, and Sonic Healthcare
ACCESSWIRE - Fri Jan 22, 7:35AM CST
NEW YORK, NY / ACCESSWIRE / January 22, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Danone SA (OTC: DANOY), Industria de Diseno Textil SA (OTC: IDEXY), Shin-Etsu Chemical Co. Ltd. (OTC: SHECY) and Sonic Healthcare Ltd. (OTC: SKHCY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Analysis of the Western European Clinical Laboratories Market 2012-2020, with 2015 as Base Year
M2 - Tue Jan 05, 9:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/tqkt5v/analysis_of_the) has announced the addition of the "Analysis of the Western European Clinical Laboratories Market" report to their offering. Laboratory consolidations and outsourcing of services are providing more opportunities to the clinical labs. How the market is going to shape up and how the laboratory services structure is transforming in Western Europe is analyzed in this research service. The study provides market overview, market engineering measurements and revenue forecasts, company profiling, and key trends for the clinical laboratory market and its segments, namely Independent reference laboratories, hospital laboratories, and physician office laboratories. Regional analysis includes Western European countries, such as the United Kingdom, Germany, France, Italy, Spain, BENELUX, and Scandinavia. The period covered in the study is 2012-2020, with 2015 as base year. Key Topics Covered: 1. Executive Summary 2. Market Overview 3. Competitive Playbook 4. External Challenges - Drivers and Restraints 5. Forecasts and Trends - Total Clinical Laboratories Market 6. Key Company Profiles 7. SWOT Analysis 8. The United Kingdom Analysis 9. Germany Analysis 10. France Analysis 11. Italy Analysis 12. Spain Analysis 13. Benelux Analysis 14. Scandinavia Analysis 15. The Last Word 16. Appendix Companies Mentioned - Biomnis - Groupe LCD - LADR - Labco - Laboratorio Dr Echevarne - Sana Kliniken - Sonic Healthcare - Synlab - Unilabs For more information visit http://www.researchandmarkets.com/research/tq...sis_of_the
United States Clinical Laboratory Services Market Report 2015
M2 - Wed Dec 16, 3:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/5fp5b5/clinical) has announced the addition of the "Clinical Laboratory Services Market" report to their offering. Clinical Laboratory Services Market, provides an in-depth market overview, a total market analysis, analysis by laboratory type, and by routine and specialty testing and a review of the latest trends driving growth. Revenues and forecasts, segment breakouts and market share presented are for the U.S. market, but international clinical lab service markets are estimated and forecasted in this report. Laboratory services are a key component of the healthcare system and an important part of the commercialization of in vitro diagnostic tests. It is estimated that approximately 80% of physician's diagnoses are a result of laboratory tests, and a fair number of these tests are sent to clinical lab service providers. There is constant pressure to reduce healthcare spending, and that in turn is shifting healthcare utilization in favor of the laboratory. This has not escaped the attention of major competitors who operate in the industry, and those planning to enter. Key market data provided includes: - The US Clinical Laboratry Market and Forecast - Markets for Tissue Pathology - Markets for Routine Chemistry Testing - Markets for Non-Tissue Molecular - Market for Toxicology/Drug Abuse Testing - European Market and Forecast - Asian Pacific Market and Forecast - Latin American Market and Forecast - Hospital, Physician and Independent Lab Statistics - Major Tests Performed by Clinical Lab Companies A competitive analysis of leading clinical laboratory providers includes: - Bio-Reference Laboratories - Da Vita Healthcare - Quest Diagnostics, Inc. - Laboratory Corporation of America (LabCorp) - Genomic Health - Genoptix - Sonic Healthcare - Myriad Genetics - Genzyme Corporation - Clarient, Inc. - Spectra Laboratories Key Topics Covered: - Executive Summary - Industry Overview - Issues And Trends In The Clinical Laboratory Industry - Leading Market Participants - Market Trends And Summary - List Of Major Companies For more information visit http://www.researchandmarkets.com/research/5fp5b5/clinical
MYGN: 30.91 (+0.83), BRLI: 34.69 (+0.08), DGX: 77.83 (+2.10), GHDX: 26.40 (+1.10)
ACCC will review Sonic Healthcare's proposed acquisition of Adelaide Pathology Partners
M2 - Mon Nov 09, 1:26AM CST
The Australian Competition and Consumer Commission will conduct a public merger review of the proposed acquisition of Adelaide Pathology Partners (APP) by Sonic Healthcare Limited and its subsidiary, Clinpath Laboratories Pty Ltd, (together, Sonic).
Global Clinical Laboratory Tests Market Analysis 2015 - Forecasts To 2020 for the $148 Billion Industry
M2 - Wed Nov 04, 4:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/kp9dqc/clinical) has announced the addition of the "Clinical Laboratory Tests Market Analysis By Product And Segment - Forecasts To 2020" report to their offering. The global market for clinical laboratory is expected to reach USD 148.82 billion by 2020, growing at an estimated CAGR of 6.8% from 2014 to 2020 Growing prevalence of chronic diseases and the development of novel laboratory testing methodologies is expected to drive the clinical laboratory tests market through to 2020. Due to the fact that results from clinical laboratory tests are the fundamental basis upon which medical practitioners and healthcare providers form their diagnosis and prognosis for the prevention and treatment for a range of diseases, clinical laboratory tests are critical to the global healthcare and medical fraternity. A growing global prevalence of medical conditions such as diabetes, obesity and other metabolic abnormalities coupled with increasing patient awareness levels is expected to boost market growth during the forecast period. For the purpose of this study, the report has segmented the clinical laboratory tests market on the basis of test type, laboratory type - Global Clinical Laboratory Tests, Test Type Outlook (Revenue, USD Billion, 2012 - 2020) - Complete Blood Count Market, by Laboratory Type - HGB/HCT Tests Market, by Laboratory Type - Basic Metabolic Panel Market, by Laboratory Type - BUN Creatinine Tests Market, by Laboratory Type - Electrolytes Testing Market, by Laboratory Type - HbA1c Tests Market, by Laboratory Type - Comprehensive Metabolic Panel Market, by Laboratory Type - Liver Panel Tests Market, by Laboratory Type - Renal Panel Tests Market, by Laboratory Type - Lipid Panel Tests Market, by Laboratory Type - Clinical Laboratory Tests Regional Outlook (Revenue, USD Billion, 2012 - 2020) Competitive Landscape - Siemens - Charles River Laboratories - Quest Diagnostics Inc. - Bioscientia Healthcare - Sonic Healthcare Limited - Abbott Laboratories - Bio-Reference Laboratories - Labco S.A. - Healtscope Limited - Spectra Laboratories - Laboratory corporation of America Holdings (Labcorp) - ARUP Laboratories - Genoptix Medical Laboratory - Qiagen - Clarient Inc. - Genzyme Corporation For more information visit http://www.researchandmarkets.com/research/kp9dqc/clinical
ABT: 37.77 (+0.38), BRLI: 34.69 (+0.08), DGX: 77.83 (+2.10), LH: 127.46 (+1.76)
Ariosa Diagnostics' Harmony(TM) Prenatal Test now performed in Australia and United Kingdom at Sonic Healthcare laboratories
PR Newswire Europe - Tue Oct 13, 9:00AM CDT
Non-invasive prenatal test assessing Down syndrome risk expands international reach
ROG: 63.38 (+1.37)
Healthcare Cloud Leader hc1.com(R) Announces Record Growth and Client Expansion
Marketwired - Thu Sep 17, 7:30AM CDT
hc1.com, inventor of the world's leading healthcare relationship management platform, today announced that it has achieved record sales growth fueled by new client additions and its best in class annually recurring revenue (ARR) renewal rate of 129%.
Drug of Abuse Testing Market Development and Demand Forecast to 2020 - The Market is Expected to Reach $3.9 billion in 2020
M2 - Wed Aug 19, 6:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9lvnjl/global_industry) has announced the addition of the "Global Industry Insight: Drug of Abuse Testing Market Development and Demand Forecast to 2020" report to their offering. Drug of abuse testing is based on diagnosing drug addiction, also called substance use disorder, requiring a thorough evaluation and often includes an assessment by a psychiatrist, a psychologist, or a licensed alcohol and drug counselor. Blood, urine or other lab tests are used to assess drug use, but they're not a diagnostic test for addiction. These tests may be used for monitoring treatment. The testing technologies consist of immunoassay technique and chromatography technique, used for both onsite as well as laboratory testing. Key findings of Drug of Abuse Testing Market: - Onsite testing market is more than double the size of laboratory testing market due to ease of use, cost effectiveness and immediate results. - North America was the largest market by geography for drug abuse testing in 2014, with 76.4% share of the total market. It was followed by Europe with 16.4% share and Asia with a 4.7% share of the total market. Report Coverage - Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis - Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market - Uncovers potential demands in the market Key Topics Covered: 1. Research Scope & Methodology 2. Executive Summary 3. Market Outlook 4. Global Market Size & Forecast (2011-2020) 5. Global Market Breakdown by Type of Test 6. Global Market Breakdown by Sample 7. Global Market Breakdown by Region 8. Competitive Analysis 9. Company Profiles 10. Appendix Companies Mentioned - Abbott Laboratories - Alere Inc. - Bio-Rad Laboratories, Inc. - Laboratory Corporation of America Holdings - Psychemedics Corporation - Quest Diagnostics - Randox Laboratories Ltd - Roche Holding Limited - Sonic Healthcare - Thermo Fisher Scientific Inc. For more information visit http://www.researchandmarkets.com/research/9l...l_industry
PMD: 13.34 (-0.18), ABT: 37.77 (+0.38), DGX: 77.83 (+2.10), LH: 127.46 (+1.76), ALR: 41.99 (-0.31)
Belgian Start-up UgenTec Receives Funding from European Investors
PR Newswire Europe - Fri Apr 10, 8:00AM CDT
-- Develops FastFinder Software Platform for Automating DNA Analysis
Global Alcohol Breathalyzer And Drug Testing Equipment Report 2014-2020 - Market Shares, Strategies, and Forecasts
M2 - Wed Nov 26, 5:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/rf99gs/alcohol) has announced the addition of Wintergreen Research, Inc's new report "Global Alcohol Breathalyzer And Drug Testing Equipment Report 2014-2020 - Market Shares, Strategies, and Forecasts" to their offering. The drug testing segment starts out as a low 29% percent of the drug and alcohol abuse detection market in 2013 and grows to be 66% of the market by 2020 responding in part to the sheer danger of the heroin drugs. The terrorists have promised to be flooding the US with opiates and heroin, wrecking the country from the inside. This is a tremendous danger, cheap heroin. The drug testing represents a deterrent as significant as military deterrent or more so to protect the citizens from direct attack. Alternatives to bars are emerging. Sports clubs have sprung up all over, creating clubs where people can meet and interact without going to a bar. The fact that alternative socialization venues exist is making it easier to enforce laws against drinking and driving. Alcohol related accidents kill someone every 31 minutes and injure someone every 2 minutes in the US. Alcohol and drugs cause serious disruption to the workforce when present among employees. Breath and saliva contain markers that can be used to monitor alcohol abuse, drug abuse, and the health status of patients. In the U.S. nearly half of road accidents are estimated to occur due to excessive alcohol consumption and drug abuse. Similarly, the number of deaths soared by 26% in Britain due to drunk driving in 2012. Thus, alcohol enforcements remain a priority for governments across the globe. Governments of various countries are strictly enforcing safety laws and are heavily emphasizing on work safety issues. Moreover, they are compelling organizations, vehicle owners and others to install portable breath analyzers at their work places. In the global breath analysis market, the fuel cell technology segment accounted for the largest share and is anticipated to lead the market during the forecast period. The growth in this segment is attributed to technology efficiency, accuracy and the increasing popularity of breath testing devices. Key Topics: - AMP Amphetamine Testing - Alcohol Breathalyzer - BZO Benzodiazepines Testing - Breath Analyzer - Breath Test Evidence - COC Cocaine Testing - Cannabis Testing - Combination Module Testing - Drug Abuse Test Kits - Drug Identification Kits - Drug Test Key Cup - Drug Testing - Employee Alcohol and Drug Testing - Fuel Cell Sensor - Hair Drug Test Kits - Healthcare Biosensor - Healthcare Breath Diagnostic Test - K2 - Law Enforcement Testing - OPI Morphrine Testing - Oral Fluid Drug Test Kit - Personal Breathalyzer - Rapid Detect Dip Drug - Saliva Drug Test Kits - Spice - Synthetic Drug Compounds - THC Testing - Urine Drug Test Kits Market Participants: - AK Solutions - Abbott Laboratories - Alcolizer - Alcovisor - Applied Nanodetectors - Bio-Rad Laboratories - Breathalyzers - CLIAWaived - DOT Breathalyzers - EBI - Express Diagnostic - KHN Solutions LLC Bactrack Breathalyzers - Lab Corp - Ladybug Teknologies - National Patent Analytic Systems (NPAS) / Datamaster - OmegaPoint Systems - Psychemedic - Quest Products - Randox Laboratories - Rapid Detect Inc. - Rapid Exams - Roche Diagnostics - Sonic Healthcare - Test Country - Thermo Fisher Scientific - TruTouch - okyoflash - uVera Diagnostics For more information visit http://www.researchandmarkets.com/research/rf99gs/alcohol
ABT: 37.77 (+0.38)
Global Drug Abuse Testing Market Outlook 2018 - Increase in Number of Collaborations and M&A
M2 - Thu Nov 06, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/dtmmdp/global_drug_abuse) has announced the addition of the "Global Drug Abuse Testing Market 2014-2018" report to their offering. The Global Drug Abuse Testing market to grow at a CAGR of 4.71% over the period 2013-2018 To calculate the market size, the report considers the revenue generated from sales of drug abuse testing solutions, which includes drug abuse testing kits and systems. The technologies primarily considered in the report are immunoassay and chromatography. One of the major trends upcoming in the market is the increase in the number of collaborations and M&A in the market. This strategy helps vendors to expand their portfolio as well as improve the quality and performance of their products. According to the report, the rising consumption of illicit drugs is a major driver in the Global Drug Abuse Testing market as the use of illicit drugs in developed as well as in developing countries is increasing worldwide. Further, the report states that one of the key challenges that the market faces is the inability of drug abuse testing products to detect low-dose designer drugs. The detection of designer drugs such as ecstasy, Rohypnol, and LSD is very difficult. Key Vendors - Bio-Rad Laboratories - Danaher - F. Hoffmann-La Roche - Siemens - Thermo Fisher Scientific Other Prominent Vendors - Abbott Laboratories - Agilent Technologies - Alere - Biomedical Diagnostics - Branan Medical - OraSure Technologies - PerkinElmer - Psychemedics - Quest Diagnostic - Randox Laboratories - Sigma-Aldrich - Sonic Healthcare - Waters Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Overview - Market Landscape - Market Segmentation by Technique - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/dt...drug_abuse
PMD: 13.34 (-0.18), ABT: 37.77 (+0.38), A: 46.12 (+0.76), DHR: 98.79 (+1.03), PKI: 53.18 (+0.83), OSUR: 6.87 (-0.07)
DynaLIFE(DX) Seeks Information on AHS Decision to Award Australian Company Lab Services
CNW Group - Tue Oct 21, 4:17PM CDT
Clarification important for Alberta Patients
